Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Pre-Filled Syringes Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.
World revenue for the Pre-Filled Syringes Market is forecast to surpass US$ 5 billion in 2024, with strong revenue growth through to 2034.
Technological Advancements in Pre-filled Injectors
Pre-filled injectors find application primarily in hospital emergency departments and for managing specific chronic conditions. These drugs are often used to treat chronic conditions such as rheumatoid arthritis, diabetes, cancer, and autoimmune disorders. This trend will contribute to market growth during the forecast period include the increasing demand for biotechnology drugs presenting expanded opportunities for biotech industry growth. The advanced therapies, often requiring precise dosing and stringent safety measures, find an ideal match in prefilled syringes.
These syringes offer convenience, accuracy, and sterility, ensuring patients receive the correct dosage with reduced risk of contamination. With the rising demand for biologics to manage chronic conditions, prefilled syringes emerge as a preferred delivery method, enhancing patient adherence and treatment outcomes while minimizing waste and improving overall healthcare efficiency.
Increase in Patient Convenience and Compliance
Patient convenience and compliance play crucial roles in driving adoption and usage of prefilled syringes. Prefilled syringes offer significant advantages over traditional vials and ampoules, particularly in terms of convenience and ease of use for patients. With prefilled syringes, patients can avoid the need for manual drawing of medication, reducing preparation time and simplifying administration. This streamlined process not only enhances convenience but also encourages patient compliance with prescribed treatment regimens.
By eliminating potential barriers to adherence, such as complicated dosing procedures or fear of needle handling, prefilled syringes contribute to better treatment outcomes and improved patient satisfaction. Overall, the focus on patient convenience and compliance serves as a key driver in the continued growth and adoption of prefilled syringes in healthcare settings.
Key Market Dynamics
Market Driving Factors
- Emerging Movement Towards Home-based Healthcare
- Rising Uptake of Injectable Medications
- Innovative Solutions Addressing the Escalating Need for Pre-Filled Syringes
Market Restraining Factors
- Challenges in the Manufacturing Process
- Presence of Alternative Drug Administration Techniques
- Sterilization Difficulties and the Presence of More Economical Alternatives
Market Opportunities
- Expansion of Biologicals and Biosimilars
- Surge in the Need for Pre-Filled Injectable Drugs
- Favourable Opportunities in Biotech Industry
Forecasts to 2034 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2034, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Pre-Filled Syringes prices and recent developments.
Segments Covered in the Report
By Type
- Conventional
- Safety
By Material
- Glass
- Plastic
- Stainless Steel
- Elastomer
By Design
- Single-chamber
- Dual-chamber
- Customized
By Delivery
- Intravenous
- Subcutaneous
- Intramuscular
- Others
By Application
- Diabetes
- Rheumatoid Arthritis
- Anaphylaxis
- Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 28 leading national markets.
Leading companies profiled in the report
- Baxter International Inc.
- BD
- Biocon
- Cardinal Health
- Catalent
- Datwyler Holding
- Debiotech
- Elcam Medical
- Fresenius Kabi
- Gerresheimer
- Jiangsu Micsafe Medical Technology
- MedXL
- Nipro Medical
- Owen Mumford
- Scandinavian Health Limited (SHL) Group
- Schott
- Stevanato Group
- Terumo
- Vetter Pharma
- West Pharmaceutical Services
The report provides you with the following knowledge:
- Revenue forecasts to 2034 for Pre-Filled Syringes Market, 2024 to 2034, with forecasts for material, design, type, delivery and application, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2034 for five regional and 27 key national markets - See forecasts for the Pre-Filled Syringes Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 20 of the major companies involved in the Pre-Filled Syringes Market, 2024 to 2034.
For more information about this report visit https://www.researchandmarkets.com/r/m1awiq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
